相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma
Catherine Lee et al.
NATURE COMMUNICATIONS (2019)
A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases
Livia Garzia et al.
CELL (2018)
Survival Following Tumor Recurrence in Children With Medulloblastoma
Donna L. Johnston et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2018)
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
Sebastian M. Waszak et al.
LANCET ONCOLOGY (2018)
Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial
Giles W. Robinson et al.
LANCET ONCOLOGY (2018)
Targeting the PI3K pathway in cancer: are we making headway?
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma
Teresa Purzner et al.
SCIENCE SIGNALING (2018)
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study
Edward C. Schwalbe et al.
LANCET ONCOLOGY (2017)
The whole-genome landscape of medulloblastoma subtypes
Paul A. Northcott et al.
NATURE (2017)
Medulloblastoma in children and adolescents: a systematic review of contemporary phase I and II clinical trials and biology update
Francisco Bautista et al.
CANCER MEDICINE (2017)
Quality of life in long-term survivors treated for metastatic medulloblastoma with a hyperfractionated accelerated radiotherapy (HART) strategy
L. Veneroni et al.
CHILDS NERVOUS SYSTEM (2017)
Inhibition of CDK4/6 by Palbociclib Significantly Extends Survival in Medulloblastoma Patient-Derived Xenograft Mouse Models
Michelle L. Cook Sangar et al.
CLINICAL CANCER RESEARCH (2017)
Intertumoral Heterogeneity within Medulloblastoma Subgroups
Florence M. G. Cavalli et al.
CANCER CELL (2017)
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
Vijay Ramaswamy et al.
ACTA NEUROPATHOLOGICA (2016)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
A Recurrent Mosaic Mutation in SMO, Encoding the Hedgehog Signal Transducer Smoothened, Is the Major Cause of Curry-Jones Syndrome
Stephen R. F. Twigg et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma
Yanxin Pei et al.
CANCER CELL (2016)
Medulloblastoma stem cells: Promising targets in medulloblastoma therapy
Guo-Hao Huang et al.
CANCER SCIENCE (2016)
Medulloblastoma
Nathan E. Millard et al.
JOURNAL OF CHILD NEUROLOGY (2016)
Intellectual Outcome in Molecular Subgroups of Medulloblastoma
Iska Moxon-Emre et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters
Andre O. von Bueren et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
Eric M. Thompson et al.
LANCET ONCOLOGY (2016)
Long-term toxic eff ects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study
Torunn I. Yock et al.
LANCET ONCOLOGY (2016)
Divergent clonal selection dominates medulloblastoma at recurrence
A. Sorana Morrissy et al.
NATURE (2016)
BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
Hengrui Zhu et al.
CELL REPORTS (2016)
Medulloblastoma subgroups remain stable across primary and metastatic compartments
Xin Wang et al.
ACTA NEUROPATHOLOGICA (2015)
From cytopenia to leukemia: the role of Gfi1 and Gfi1b in blood formation
Tarik Moeroey et al.
BLOOD (2015)
Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment
Todd VanArsdale et al.
CLINICAL CANCER RESEARCH (2015)
Panobinostat for the Treatment of Multiple Myeloma
Jacob P. Laubach et al.
CLINICAL CANCER RESEARCH (2015)
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032
Giles W. Robinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Survival of children with medulloblastoma in Canada diagnosed between 1990 and 2009 inclusive
Donna L. Johnston et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
MRI Surrogates for Molecular Subgroups of Medulloblastoma
S. Perreault et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2014)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma
Paul A. Northcott et al.
NATURE (2014)
Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
Vijay Ramaswamy et al.
LANCET ONCOLOGY (2013)
Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961
Roger J. Packer et al.
NEURO-ONCOLOGY (2013)
Molecular subgroups of medulloblastoma: the current consensus
Michael D. Taylor et al.
ACTA NEUROPATHOLOGICA (2012)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool et al.
ACTA NEUROPATHOLOGICA (2012)
Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study
Regina I. Jakacki et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
High Frequency of Germline SUFU Mutations in Children With Desmoplastic/Nodular Medulloblastoma Younger Than 3 Years of Age
Laurence Brugieres et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations
Trevor J. Pugh et al.
NATURE (2012)
Novel mutations target distinct subgroups of medulloblastoma
Giles Robinson et al.
NATURE (2012)
Dissecting the genomic complexity underlying medulloblastoma
David T. W. Jones et al.
NATURE (2012)
Clonal selection drives genetic divergence of metastatic medulloblastoma
Xiaochong Wu et al.
NATURE (2012)
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott et al.
NATURE (2012)
Clinical and neuroanatomical predictors of cerebellar mutism syndrome
Nicole Law et al.
NEURO-ONCOLOGY (2012)
Phase I Trial of Hedgehog Pathway Inhibitor Vismodegib (GDC-0449) in Patients with Refractory, Locally Advanced or Metastatic Solid Tumors
Patricia M. LoRusso et al.
CLINICAL CANCER RESEARCH (2011)
Adult Medulloblastoma Comprises Three Major Molecular Variants
Marc Remke et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
Yoon-Jae Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medulloblastoma Comprises Four Distinct Molecular Variants
Paul A. Northcott et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Role of High-Dose Chemotherapy for Recurrent Medulloblastoma and Other CNS Primitive Neuroectodermal Tumors
Amar Gajjar et al.
PEDIATRIC BLOOD & CANCER (2010)
Hyperfractionated Accelerated Radiotherapy in the Milan Strategy for Metastatic Medulloblastoma
Lorenza Gandola et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Management of and Prognosis With Medulloblastoma Therapy at a Crossroads
Roger J. Packer et al.
ARCHIVES OF NEUROLOGY (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
Steven C. Clifford et al.
CELL CYCLE (2006)
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial
Amar Gajjar et al.
LANCET ONCOLOGY (2006)
Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma
Roger J. Packer et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genornics identifies medulloblastoma subgroups that are enriched for specific genetic alterations
MC Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Outcome of medulloblastoma in children: Long-term complications and quality of life
K Ribi et al.
NEUROPEDIATRICS (2005)
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone
S Rutkowski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Mutations in SUFU predispose to medulloblastoma
MD Taylor et al.
NATURE GENETICS (2002)
Harvey Cushing and medulloblastoma
LJ Kunschner
ARCHIVES OF NEUROLOGY (2002)
Prediction of central nervous system embryonal tumour outcome based on gene expression
SL Pomeroy et al.
NATURE (2002)
分享论文
